CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 41.232
AS - Asia 24.176
EU - Europa 20.404
SA - Sud America 4.979
AF - Africa 702
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 41
Totale 91.585
Nazione #
US - Stati Uniti d'America 40.459
SG - Singapore 8.722
CN - Cina 7.915
UA - Ucraina 5.138
BR - Brasile 4.174
IT - Italia 3.913
HK - Hong Kong 2.959
DE - Germania 2.701
FI - Finlandia 1.587
VN - Vietnam 1.455
PL - Polonia 1.454
FR - Francia 1.320
GB - Regno Unito 1.181
TR - Turchia 992
RU - Federazione Russa 920
IE - Irlanda 885
IN - India 672
SE - Svezia 419
CA - Canada 371
AR - Argentina 294
BD - Bangladesh 291
MX - Messico 253
IQ - Iraq 185
ZA - Sudafrica 181
NL - Olanda 176
AT - Austria 167
ID - Indonesia 148
ES - Italia 135
EC - Ecuador 134
PK - Pakistan 118
JP - Giappone 116
CO - Colombia 97
SA - Arabia Saudita 92
BE - Belgio 80
BF - Burkina Faso 72
MA - Marocco 72
UZ - Uzbekistan 72
VE - Venezuela 70
PY - Paraguay 62
CZ - Repubblica Ceca 58
CL - Cile 54
MU - Mauritius 54
LT - Lituania 53
NG - Nigeria 53
EG - Egitto 47
AU - Australia 45
KE - Kenya 45
JO - Giordania 44
EU - Europa 38
JM - Giamaica 37
PH - Filippine 36
UY - Uruguay 36
IR - Iran 35
AE - Emirati Arabi Uniti 34
AZ - Azerbaigian 33
ET - Etiopia 32
IL - Israele 32
TN - Tunisia 32
PE - Perù 31
GH - Ghana 27
MY - Malesia 26
NP - Nepal 24
PT - Portogallo 24
CR - Costa Rica 23
DZ - Algeria 23
CH - Svizzera 22
AL - Albania 20
RO - Romania 19
BO - Bolivia 18
HN - Honduras 18
KZ - Kazakistan 18
OM - Oman 18
LB - Libano 16
PA - Panama 15
DO - Repubblica Dominicana 14
TT - Trinidad e Tobago 14
HR - Croazia 13
KR - Corea 12
BH - Bahrain 11
CM - Camerun 11
GR - Grecia 11
KG - Kirghizistan 11
LK - Sri Lanka 11
RS - Serbia 11
TH - Thailandia 11
BG - Bulgaria 10
BY - Bielorussia 10
SK - Slovacchia (Repubblica Slovacca) 10
CI - Costa d'Avorio 9
MD - Moldavia 9
PS - Palestinian Territory 9
HU - Ungheria 8
KH - Cambogia 8
AM - Armenia 7
BB - Barbados 7
EE - Estonia 7
LV - Lettonia 7
NI - Nicaragua 7
SI - Slovenia 7
BA - Bosnia-Erzegovina 6
Totale 91.443
Città #
Singapore 4.692
Jacksonville 3.636
Fairfield 3.587
Ashburn 3.429
Hong Kong 2.947
Woodbridge 2.881
Chandler 2.141
Wilmington 2.002
Houston 1.771
Princeton 1.601
The Dalles 1.537
Cambridge 1.467
Ann Arbor 1.463
Seattle 1.449
Beijing 1.442
Warsaw 1.433
San Jose 1.344
Nanjing 1.235
New York 1.043
Dublin 872
Helsinki 842
Lauterbourg 800
Istanbul 785
Los Angeles 774
Ho Chi Minh City 488
Munich 443
Nanchang 426
Buffalo 417
Brescia 413
Des Moines 411
Milan 396
São Paulo 378
Council Bluffs 352
Moscow 319
Shenyang 316
Changsha 295
Hanoi 280
Dallas 272
Hebei 264
Chicago 236
San Diego 236
Tianjin 235
Jinan 210
Dearborn 202
Jiaxing 196
Redondo Beach 195
Shanghai 195
Orem 174
San Francisco 174
Nuremberg 159
London 158
Santa Clara 152
Hangzhou 151
Kunming 144
Rio de Janeiro 139
Rome 126
Verona 124
Boardman 116
Turku 116
Toronto 115
Frankfurt am Main 109
Tokyo 107
Montreal 99
Mexico City 97
Chennai 96
Kocaeli 94
Brooklyn 90
Johannesburg 88
Zhengzhou 88
Guangzhou 85
Mcallen 83
Belo Horizonte 82
Denver 81
Brussels 78
Ningbo 78
Brasília 77
Phoenix 73
Manchester 72
Stockholm 71
Vienna 71
Lanzhou 69
Tashkent 68
Ouagadougou 67
Atlanta 66
Baghdad 66
Haiphong 66
Lancaster 66
Boston 64
Salt Lake City 64
Romola 61
Jakarta 60
Poplar 59
Curitiba 58
Dong Ket 58
Norwalk 56
Amsterdam 55
Da Nang 55
Mumbai 55
Porto Alegre 53
Guarulhos 49
Totale 57.130
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 466
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 416
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 291
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 289
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 265
Proceedings of the IV Congress of the University Network for Development Cooperation (CUCS) “Rinforzare il capitale umano nei paesi a risorse limitate: health and wealth for all by the year 2030” 259
Cos’è la Medicina Tropicale 250
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data 245
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 241
Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 240
Arboviral and other illnesses in travellers returning from Brazil, june 2013 to may 2016: Implications for the 2016 olympic and paralympic games 239
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 231
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 224
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 224
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 217
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 216
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: Results from the Italian MASTER Cohort 213
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection 209
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 203
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 203
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 202
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 201
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 200
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 199
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 198
Towards tuberculosis elimination: An action framework for low-incidence countries 196
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 195
A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from singapore 194
Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy 191
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 187
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV 186
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 185
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 178
Malaria chemoprophylactic recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study 178
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 178
Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study 177
A first update on mapping the human genetic architecture of COVID-19 176
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 176
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 175
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 175
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 173
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 173
Non-typhoidal Salmonella aortitis 172
Mapping the human genetic architecture of COVID-19 171
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 171
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 171
Louse-borne relapsing fever in a refugee from Mali 170
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 169
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 169
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 167
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 167
ABDOMINAL AORTITIS AND ANEURYSM IMPENDING RUPTURE DURING PNEUMOCOCCAL MENINGITIS 167
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 167
Accidental and transfusion malaria in Italy 165
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 165
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 164
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 163
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy 163
Epidemiology of malaria in endemic areas 162
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 162
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 161
Advances in the treatment of malaria 160
Differential diagnosis of illness in travelers arriving from sierra Leone, Liberia, or guinea: A cross-sectional study from the Geosentinel surveillance network 160
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 160
A COPD case-finding program in a large cohort of HIV-infected persons 160
Migration Medicine: the Challenge of Tuberculosis 159
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 159
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 159
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 159
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 159
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 158
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 157
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 157
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea 155
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 155
A Case of Rickettsia felis Infection Imported from Nepal 155
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 155
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 154
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 154
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 154
Simultaneous Diagnosis of Acute Crohn's Disease and Endometriosis in a Patient Affects HIV 154
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 154
Correction to: Acute epididymo-orchitis due to Salmonella Typhi in a young man from Bangladesh. 154
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 153
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 153
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C 153
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 153
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 152
Filariasis in travelers presenting to the Geosentinel Surveillance Network 151
Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean 151
A Strange Manifestation of Malaria in a Native Nigerian Boy 151
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 150
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 149
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 149
Peripheral loss of regulatory T cells and polyautoimmunity in an HIV-infected patient 148
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy,1999-2009 148
STI epidemics in the Indian Ocean Region: can the phase be assessed? 147
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 147
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 147
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 147
Totale 18.400
Categoria #
all - tutte 459.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 459.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.410 0 0 0 0 0 0 0 0 0 1.012 1.098 300
2021/20225.840 307 1.165 114 395 89 327 250 459 330 693 506 1.205
2022/20236.001 918 106 104 597 541 1.597 18 623 927 50 232 288
2023/20245.249 378 176 396 331 222 926 176 205 1.326 69 108 936
2024/202514.206 121 74 132 1.544 1.695 1.230 1.297 596 1.556 1.247 2.930 1.784
2025/202625.924 2.578 3.709 2.113 4.285 2.602 1.844 4.075 1.139 1.825 1.754 0 0
Totale 92.732